TheraRadar
← Back
Data updated: Mar 29, 2026

STRIDES PHARMA INTL

CardiovascularInfectious DiseaseImmunology
Generics

STRIDES PHARMA INTL is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Immunology. Key products include LYVISPAH.

1953
Since
72
Drugs
-
Trials
1147
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 45%
5 drugs
Infectious Disease 27%
3 drugs
Immunology 9%
1 drugs
Dermatology 9%
1 drugs
Metabolic 9%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...